GILD

Gilead Sciences, Inc. News Headlines

$107.4479
*  
1.9079
1.81%
Get GILD Alerts
*Delayed - data as of Jan. 26, 2015 12:21 ET  -  Find a broker to begin trading GILD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    GILD Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
This Switch Could Make Gilead Sciences, Inc. Stock Billions
9/25/2014 11:01:02 AM - Motley Fool


Gilead: Growth Prospects Are Not Over Yet
9/25/2014 8:37:00 AM - Seeking Alpha


The Best Biotech Stock for Your Growth Portfolio
9/25/2014 7:45:02 AM - Motley Fool


Novavax's Influenza Vaccine Study Shows Adjuvant Efficiency - Analyst Blog
9/24/2014 5:10:00 PM - Zacks.com


Gilead (GILD) Seeks Japanese Approval for HCV Combo Drug - Analyst Blog
9/24/2014 5:00:00 PM - Zacks.com


Celgene's Otezla Label Expanded to Include Plaque Psoriasis - Analyst Blog
9/24/2014 4:30:00 PM - Zacks.com


Emergent BioSolutions Initiates Pivotal Study on BioThrax - Analyst Blog
9/24/2014 4:20:00 PM - Zacks.com


Update: TAF Delivers For Gilead
9/24/2014 1:00:00 PM - Seeking Alpha


Gilead: Could Japan Power Next Major Leg Of The Rally?
9/24/2014 11:08:00 AM - Seeking Alpha


Why A $150 Price Target On Gilead Is More Than Possible
9/24/2014 9:44:00 AM - Seeking Alpha


Acceleron Pharma (XLRN) Jumps: Stock Rises 12.8% - Tale of the Tape
9/24/2014 8:39:00 AM - Zacks.com


Incyte: Increasing Sales, Deep Pipeline, Multiple Catalysts, With A Side Of M&A Chatter
9/19/2014 11:58:00 AM - Seeking Alpha


Gilead Emerging Market Agreement: Huge Win For Patients, Non-Event For Investors.
9/19/2014 9:26:00 AM - Seeking Alpha


Gilead: Still 50% Upside Left In The Stock
9/18/2014 11:12:00 AM - Seeking Alpha


Gilead Sciences: The Recent Dip In Share Price Creates A Buying Opportunity
9/18/2014 10:55:00 AM - Seeking Alpha


What Makes Mylan Attractive
9/18/2014 8:36:00 AM - Seeking Alpha


The Growing Problem For Income Investors
9/17/2014 11:32:00 AM - Seeking Alpha


Could GlaxoSmithKline Be A Better Investment Than Gilead?
9/17/2014 10:06:00 AM - Seeking Alpha


Buy The Dip In Gilead: Why A Decrease In Quarterly Sovaldi Revenue Is Expected
9/16/2014 12:31:00 PM - Seeking Alpha


ProQR Therapeutics: Competition, Distance From Clinical Trials Leads Us To Hold Off
9/16/2014 9:53:00 AM - Seeking Alpha


If Achillion's Hep C Nucleotide Isn't Best In Class, The Stock Is Worth Low Single Digits
9/16/2014 8:00:00 AM - Seeking Alpha


Is Intercept Pharmaceuticals Building The Next Great Specialty Franchise?
9/15/2014 2:30:00 PM - Seeking Alpha


Bulls Go Down Swinging, Refusing To Give Up Much Ground
9/15/2014 1:30:00 PM - Seeking Alpha


Uncertainty Prevails For Vertex
9/11/2014 3:48:00 PM - Seeking Alpha


In A Quiet Week, Affimed Therapeutics IPO Could Garner Investor Interest
9/11/2014 3:17:00 PM - Seeking Alpha